Enadoline hydrochloride

N/A

Report date: 2022/02/11 15:33:27
NME

Base Information

Drug NameEnadoline hydrochloride
Drug Alias NameCI-977PD-129290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersKappa opioid receptor antagonists
TargetsSodium channel alpha subunitKappa opioid receptor
Therapy Area/IndicationsPainTrauma, Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPainTrauma, Nervous System

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG